Lubrizol Expands Medical Tubing Production Five-Fold for Global Export

The production facility of Lubrizol in India will expand its production of medical tubing by five times, improving availability of life-saving medical tubing locally and for global markets through exports. The collaboration will result in the...

How CRDMO Leaders can Leverage the BioSecure Act for New Opportunities

In an exclusive interview with India Pharma Outlook Magazine,Kapil Choudhury, Head of Global Business Development, Aurigene Pharmaceutical Services, shares how the Indian CRDMO leaders can equip themselves for the incoming business resulting from ...

Navigating the Future of Contract Research and Manufacturing Organizations

In an exclusive interaction with India Pharma Outlook, Dr. Mahesh Bhalgat, Group CEO and MD of Veeda Clinical Research Limited discusses key trends in the CRO/CDMO industry, such as digital transformation, niche specialization, global expansion...

Venus Remedies Gains PIC/S GMP Approval for Robotic Syringe Facility

Venus Remedies announced that its robotic pre-filled syringe facility at the Baddi unit has been granted approval for good manufacturing practices (GMP) by the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia. Venus Remedies announced...

NPPA Issues Memorandum to Companies for Price Reduction on Cancer Drugs

The government has instructed companies to reduce the prices of three anti-cancer drugs in order to pass on the benefits from customs duty exemptions and reductions in GST to consumers. In line with the government’s commitment to ensuring that dru...

Latest Penicillin Plant Boasts Production Capacity of 15,000MT

Lyfius Pharma, a unit of Aurobindo Pharma, on Tuesday said Prime Minister Narendra Modi has inaugurated its Penicillin-G plant at Kakinada, Andhra Pradesh. The facility with an annual production capacity of 15,000 metric tonnes (MT) was virtually ...

Emcure Pharma Establishes Dedicated Subsidiary for Dermatology

Emcure Pharmaceuticals Limited has announced the formation of a wholly-owned subsidiary, Emcutix Biopharmaceuticals Limited, which will focus exclusively on dermatology...

India Poised to Export Over 50% of Pharma Production

In the previous year, approximately half of India’s pharmaceutical and biological products were sent overseas, signaling a significant change towards a pharmaceutical industry focused on exports as India nears exporting over 50% of its output...

PM Modi to Introduce Medical Devices and Bulk Drug Facilities

Prime Minister Narendra Modi is set to launch five projects as part of the production linked incentive (PLI) scheme for medical devices and bulk drugs today, during Dhanvantari Jayanti and 9th Ayurveda Day celebrations. He is scheduled to open...

Matica Biotech and KaliVir Ink LOI for Oncolytic Viral Immunotherapy Ties

Matica Biotechnology Inc. (Matica Bio), a company specializing in viral vector development and manufacturing, has revealed the signing of a Letter of Intent (LOI) with KaliVir Immunotherapeutics, a clinical-stage biotechnology company from the U.S...

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring